Showing results (141-150 of 147) with videos related to
Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 147 results.
The Journal of Clinical Endocrinology and Metabolism|March 21, 2022
Integrative Clinical, Radiological, and Molecular Analysis for Predicting Remission and Recurrence of Cushing DiseasePaloma Moreno-Moreno, Alejandro Ibáñez-Costa, Eva Venegas-Moreno, et al.Science Advances|October 2, 2024
SRSF6 modulates histone-chaperone HIRA splicing to orchestrate AR and E2F activity in prostate cancerAntonio J Montero-Hidalgo, Juan M Jiménez-Vacas, Enrique Gómez-Gómez, et al.Cell Communication and Signaling : CCS|May 15, 2026
Periprostatic adipose tissue-derived adipokine profile in prostate cancer patients reveals two distinct molecular phenotypes linked to obesity-related comorbidities: multifaceted role of lipocalin-2Jesús M Pérez-Gómez, Antonio Prats-Escribano, Ignacio Gil-Duque, et al.Journal of Experimental & Clinical Cancer Research : CR|December 3, 2021
Dysregulated splicing factor SF3B1 unveils a dual therapeutic vulnerability to target pancreatic cancer cells and cancer stem cells with an anti-splicing drugEmilia Alors-Perez, Ricardo Blázquez-Encinas, Sonia Alcalá, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 12, 2026
The telomerase/shelterin system is impaired in acromegaly and Cushing´s disease: Potential pathophysiological relevanceMiguel E G-García, Ana S De la Rosa-Herencia, Ignacio Gil-Duque, et al.Gastroenterologia Y Hepatologia|May 9, 2024
Proceedings of the 5th Meeting of Translational Hepatology, organized by the Spanish Association for the Study of the Liver (AEEH)Edilmar Alvarado-Tapias, Douglas Maya-Miles, Agustin Albillos, et al.Cell Reports|March 20, 2024
SUMOylation controls Hu antigen R posttranscriptional activity in liver cancerSofia Lachiondo-Ortega, Claudia M Rejano-Gordillo, Jorge Simon, et al.Pageof 15